Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the benefit to patients with empyema or complicated
parapneumonic effusion (CPE) using a daily versus twice daily Alteplase regimen of two
different dose strategies compared with saline placebo.
Phase:
N/A
Details
Lead Sponsor:
O'Brien, Jeana D., MD, FACP, FCCP
Collaborators:
Genentech, Inc. Scott and White Hospital & Clinic Scott, Sherwood and Brindley Foundation Texas A&M University